English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

pectin/inflammation

The link is saved to the clipboard
9 results

Binding of galectin-3 by low molecular weight pectin

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

Binding of galectin-3 by low molecular weight pectin

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

Binding of galectin-3 by low molecular weight pectin

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

Feed compositions for preventing and treating inflammatory diseases

Only registered users can translate articles
Log In/Sign up
This application is the U.S. National Phase under 35 U.S.C. .sctn. 371 of International Application No. PCT/EP2016/066351, filed Jul. 8, 2016, designating the U.S., and published in English as WO 2017/009257 A2 on Jan. 19, 2017, which claims priority to European Patent Application No. 15176285.3,

Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins

Only registered users can translate articles
Log In/Sign up
FEDERALLY SPONSORED RESEARCH Not Applicable SEQUENCE LISTING OR PROGRAM Not Applicable BACKGROUND OF THE INVENTION 1. Field of Invention The present application generally relates to nutrition, in particular an ultra-high fiber supplement, the making of the supplement, and its use in weight loss,

Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins.

Only registered users can translate articles
Log In/Sign up
FEDERALLY SPONSORED RESEARCH Not Applicable SEQUENCE LISTING OR PROGRAM Not Applicable BACKGROUND OF THE INVENTION 1. Field of Invention The present application generally relates to nutrition, in particular an ultra-high fiber supplement, the making of the supplement, and its use in weight loss,

Reduction of galectin-3 levels by plasmapheresis

Only registered users can translate articles
Log In/Sign up
PRIORITY DATA AND INCORPORATION BY REFERENCE This application claims benefit of priority to U.S. Provisional Patent Application No. 61/568,210 filed Dec. 8, 2011 which is incorporated by reference in its entirety. BACKGROUND OF THE INVENTION 1. Field of the Invention This invention pertains to

Galectin-3 plasmapheresis therapy

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Field of the Invention This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate

Galectin-3 plasmapheresis therapy

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Field of the Invention This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge